Skip to main content

Table 3 C-reactive protein and nerve-growth-factor levels in urine and serum samples

From: Measurements of C-reactive protein (CRP) and nerve-growth-factor (NGF) concentrations in serum and urine samples of dogs with neurologic disorders

 

CRP urine

ng/ml

CRP/Crea urine

CRP serum ng/ml

NGF urine

NGF/Crea urine

NGF serum

pg/ml

Control

1.08

(0–1.76)

0.01

(0–0.02)

946

(0–6820)

76.60

(7.17-250)

0.50

(0.06-3.01)

179

(104–250)

Neurological Disorders

2.21

(0–11.39)

0.04

(0–0.26)

22452

(0–208658)

31.98

(0–150)

0.61

(0–2.41)

164

(40–250)

SC

01.45

(0–14.91)

0.02

(0–0.1721)

14764

(0–92035)

63.24

(0–198)

1.00

(0–3.43)

166

(24.77-250)

SC MD

9.22

(0–131)

0.12

(0–1.1462)

9235

(0–81719)

58.11

(0–250)

0.73

(0–4.40)

167

(46–250)

  1. C-reactive protein (CRP) and nerve-growth-factor (NGF) levels in urine and serum samples (mean, range in brackets), CRP/Creatinine and NGF/Creatinine ratios in the different groups: control group (n = 20), neurological disorders (n = 14), spinal cord disorders without micturition dysfunctions (SC) (n = 15) and spinal cord disorders with micturition dysfunctions (SC MP) (n = 27)